Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 16, 2019
Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapyThibault Mazard, Eric Assenat, Marie Dupuy, et al.
Bulletin Du Cancer|October 9, 2014
[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France]Jean-Yves Pierga, Rémy Delva, Xavier Pivot, et al.
Plos One|January 24, 2019
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approachEnora Laas, Anne-Sophie Hamy, Anne-Sophie Michel, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 12, 2008
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?Véronique Girre, Marie-Christine Falcou, Mathilde Gisselbrecht, et al.
Lab on a Chip|March 28, 2015
High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detectionJulien Autebert, Benoit Coudert, Jérôme Champ, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancerRomain-David Seban, Laurence Champion, Alexandre De Moura, et al.
British Journal of Cancer|February 9, 2021
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-BioscoreEnora Laas, Julie Labrosse, Anne-Sophie Hamy, et al.
The Journal of Pain|December 25, 2013
Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort studyFrancoise Laroche, Joël Coste, Terkia Medkour, et al.
Breast (Edinburgh, Scotland)|June 19, 2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumabQuentin Jacquinot, Sophie Paget-Bailly, Pierre Fumoleau, et al.
British Journal of Cancer|January 27, 2024
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclibThomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, et al.
Pageof 25